PlatformHealthcare
Webster Equity Partners agrees to acquire Lifecore Biomedical
The pending take-private offers $6.28 per share in cash plus a contingent value right tied to milestones.
- Target
- Lifecore Biomedical
- Sponsor
- Webster Equity Partners
- Source
- ir.lifecore.com